Notice: Prescription Drug List (PDL): Sotrovimab (COVID-19)
The purpose of this Notice of Amendment is to notify about the addition of sotrovimab to the Prescription Drug List (PDL) for human and veterinary use.
- Publisher - Current Organization Name: Health Canada
- Licence: Open Government Licence - Canada
Data and Resources
-
Notice: Prescription Drug List (PDL): Sotrovimab (COVID-19)HTMLEnglish publication HTML
-
Notice: Prescription Drug List (PDL): Sotrovimab (COVID-19)HTMLFrench publication HTML
Similar records